Talaris Therapeutics

Heart-shaped diamond
Biotech

Former Pfizer antibody reduces cardio risk marker in ph. 2

Pacibekitug, an antibody Tourmaline licensed from Pfizer in 2022, reduced levels of C-reactive protein in patients with chronic kidney disease.
Darren Incorvaia May 20, 2025 7:30am
layoff staff workforce

2023 biopharma layoffs now match 2022's total

Aug 21, 2023 11:37am
merger handshake

Talaris reverse merger tees up midphase trials of ex-Pfizer drug

Jun 22, 2023 9:50am
layoffs job cuts workforce reduction layoff

Talaris lays off 95% of workforce after fruitless deal hunt

Apr 17, 2023 9:38am
organ transplant surgery cooler organ transplantation

Talaris ends recently restarted kidney transplant studies

Feb 16, 2023 11:00am
Kidney

Talaris restarts trial after assurance regarding patient death

Oct 20, 2022 10:05am